Clinical Trials Browser

Recruiting × OTHER_GOV × Gynecologic × Clear all

NCT07472140 2026-03-16

PARP (Poly (ADP-ribose) Polymerase) Inhibitor With or Without Angiogenesis Inhibitor in Homologous Recombination Deficient Primary Ovarian Cancer, Fallopian-Tube Cancer, or Primary Peritoneal Cancer

Phase 2/3 Recruiting

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT07472153 2026-03-16

PD-1 (Programmed Death-1) Versus PD-L1 (Programmed Death-ligand 1) Immune Check Point Inhibitors Combined With Chemotherapy, With or Without Bevacizumab, In Patients With Metastatic, Persistent Or Recurrent Cervical Cancer

Phase 2/3 Recruiting

Uterine Cervical Neoplasms

NCT07435623 2026-03-02

Late Radiation Toxicities in Cervical and Endometrial Cancer: A Postoperative IMRT/Brachytherapy Study

Uterine Cervical Neoplasms, Endometrial Neoplasms

NCT05102240 2026-02-20

Development of Clinically High Efficient Platforms for Individualised Treatment of Cervix Cancer

Uterine Cervical Neoplasms

NCT06264167 2026-02-20

NODE

Phase NA Recruiting

Lymphatic Metastasis, Vulvar Neoplasms

NCT06644846 2026-02-20

Spatially Fractionated Radiation Treatment for Gynaecological Cancers

Phase NA Recruiting

Uterine Cervical Neoplasms, Neoplasms, Recurrence

NCT03997110 2026-02-17

RAPPAL

Phase NA Recruiting

Uterine Cervical Neoplasms

NCT07400809 2026-02-17

Retro-COSMOS

Uterine Cervical Neoplasms, Neoplasm Metastasis, Patient Compliance, Recurrence

NCT07196033 2026-02-09

AGBR-FERN-Gyn

Stage IIIA Cervical Cancer FIGO 2018

NCT06804135 2026-02-04

STIRR

Uterine Cervical Neoplasms

NCT07290972 2026-02-04

NCG-Compliance

Uterine Cervical Neoplasms, Neoplasms, Patient Compliance, Recurrence

NCT07050745 2026-01-12

DADA-LINK

Phase NA Recruiting

Uterine Cervical Neoplasms

NCT07181278 2025-12-02

OptiTri_MT

Phase NA Recruiting

Uterine Cervical Neoplasms

NCT07248553 2025-11-25

LNG-IUD TIMING

Ovarian Cysts

NCT05236686 2025-11-19

Survival Effect of Hepato-celiac Lymphadenectomy In Primary or Relapsed Ovarian Cancer

Phase NA Recruiting

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Lymphatic Metastasis, Ovarian Neoplasms

NCT06482983 2025-11-19

The Effects of VC Versus PC Ventilation on Cerebral and Respiratory Parameters in Patients Undergoing Laparoscopic Gynecologic Surgery

Phase NA Recruiting

Anesthesia

NCT06560697 2025-10-07

SABRVICAL

Phase NA Recruiting

Uterine Cervical Neoplasms

NCT07106814 2025-09-15

Safety and Efficacy of Metabolically Armed Tumor-lnfiltrating Lymphocytes (Meta10-TIL) for the Treatment of Advanced Solid Tumors

Phase EARLY_PHASE1 Recruiting

GastrointestinalGynecologic

Uterine Cervical Neoplasms, Liver Neoplasms

NCT07171528 2025-09-12

KOV-02S

Phase 2 Recruiting

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT07169396 2025-09-11

GEN_EXP_CO2021

Ovarian Neoplasms

NCT06839144 2025-07-11

OC-POP-PT

Phase 2 Recruiting

Neoplasms, Ovarian Neoplasms

NCT06232083 2025-07-09

A Multi Tumor, Open Phase I Clinical Study on the Progression of First-line Anti-tumor Therapy Using Cardonizumab Combined With Pulsed Low-dose Rate External Irradiation (PLDR)

Phase 1 Recruiting

GastrointestinalGynecologicThoracic

Uterine Cervical Neoplasms, Esophageal Neoplasms, Lung Neoplasms

NCT07025213 2025-06-17

Metabolic Effect of Exercise and Diet in Endometrial Cancer Patients Eligible for Staging Surgery.

Phase NA Recruiting

Endometrial Neoplasms

NCT03101995 2025-05-28

Assessment of Gemcitabine as Chemoradiotherapy in Patients With Locally Advanced Carcinoma of Cervix and Renal Disease

Phase 2 Recruiting

Uterine Cervical Neoplasms, Renal Insufficiency

NCT06156514 2025-05-28

MICHELE

Phase 3 Recruiting

Locally Advanced Cervical Cancer

NCT06080841 2025-05-25

Curcumin Supplementation in Cervical Cancer

Phase NA Recruiting

Locally Advanced Cervical Cancer

NCT05200260 2025-02-10

Surgery Combined With Maintenance Targeted Therapy in the Treatment of Advanced Ovarian Cancer

Phase 2 Recruiting

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT06528184 2025-02-10

Evaluating the Impact of Different Methods of HPV DNA Testing for Cervical Cancer Screening in Primary Care Settings

Phase NA Recruiting

Uterine Cervical Neoplasms

NCT04846933 2025-01-16

DECIDER

Phase NA Recruiting

Ovarian Neoplasms

NCT06307886 2025-01-07

Comparison of Five-year Survival and Disease-free Survival in Patients Diagnosed With Endometrium Cancer Who Underwent Total Laparoscopic Hysterectomy With and Without Uterine Manipulator

Endometrial Neoplasms

NCT05855941 2024-12-16

PRODIGYN

Carcinoma, Ovarian Epithelial, Uterine Cervical Neoplasms, Endometrial Neoplasms

NCT06278857 2024-12-03

SATELLITE

Phase 2 Recruiting

Turcot syndrome, Endometrial Neoplasms

NCT06680791 2024-11-08

MPEC

Diabetes Mellitus, Hypertension, Risk-Taking, Endometrial Neoplasms, Genetic Predisposition to Disease

NCT06640348 2024-10-15

Ultrasensitive SERS Platform With Highly Efficient Enrichment of Analyte for Screening and Diagnosis of Epithelial Ovarian Cancer

Carcinoma, Ovarian Epithelial

NCT06140589 2024-09-19

Exploring the Efficacy, Safety and Cost-effectiveness Analysis of Cadonilimab in the Treatment of Cervical Cancer

Uterine Cervical Neoplasms

NCT06455046 2024-06-12

Efficacy and Safety of AK104 Combined With Chemotherapy and Recombinant Human Adenovirus 5 Injection in Cervical Cancer

Phase 2 Recruiting

Cervical Cancer Recurrent

NCT06455072 2024-06-12

Nituzumab Plus Serplulimab Combined With SBRT in Cervical Cancer

Phase 2 Recruiting

Uterine Cervical Neoplasms

NCT06405945 2024-05-09

Cervical Cancer Susceptible Population Classification

10,000 enrolled

Cervical Cancer Susceptible Population Classification

NCT06253169 2024-04-23

ASTRA

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT06206083 2024-02-28

Molecular Classification in Mexican Patients With Endometrial Cancer and Its Impact on Prognosis

Endometrial Neoplasms

NCT04519151 2023-06-08

Pembrolizumab and Lenvatinib for Platinum- Sensitive Recurrent Ovarian Cancer

Phase 2 Recruiting

GastrointestinalGynecologic

Carcinoma, Ovarian Epithelial, Genital Neoplasms, Female, Neoplasms, Neoplasms, Glandular and Epithelial, Ovarian Diseases, Ovarian Neoplasms, Stomach Neoplasms, Urogenital Neoplasms

NCT04910802 2021-09-16

Concomitant HPV Vaccination and HPV Screening HPV Infection and Cervical Cancer in Sweden

Phase 4 Recruiting

150,000 enrolled

Uterine Cervical Neoplasms, Papillomavirus Infections